Skip to main content
Clinical Trials/NCT00749970
NCT00749970CompletedNot Applicable

Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia

AstraZeneca2 sites in 1 country100 target enrollmentStarted: July 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
100
Locations
2
Primary Endpoint
SWN-K

Study Overview

Brief Summary

Observational, short-term prospective, multicenter study to assess psychometric properties of the Spanish version of SWN-K scale in patients with schizophrenia.

Study Design

Study Type
Observational
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with a diagnosis of schizophrenia, schizoaffective disorder, or schizophreniform disorder (DSM-IV TR criteria)
  • Stabilized out-patients
  • Under treatment with an oral antipsychotic drug

Exclusion Criteria

  • Administration of a depot antipsychotic drug
  • Participation in another clinical trial within 4 weeks prior to enrolment into this study

Outcomes

Primary Outcomes

SWN-K

Time Frame: 7 days

PANSS

Time Frame: 7 days

Secondary Outcomes

  • CGI-I(7 days)

Investigators

Sponsor Class
Industry

Study Sites (2)

Loading locations...

Similar Trials